Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations
- 31 January 2006
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1758 (1), 55-64
- https://doi.org/10.1016/j.bbamem.2006.01.009
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Liposome-encapsulated vincristine, vinblastine and vinorelbine: A comparative study of drug loading and retentionJournal of Controlled Release, 2005
- An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomesJournal of Controlled Release, 2004
- In vivo administration of liposomal vincristine sensitizes drug‐resistant human solid tumorsInternational Journal of Cancer, 2004
- LIPOSOMAL DAUNORUBICIN OVERCOMES DRUG RESISTANCE IN HUMAN BREAST, OVARIAN AND LUNG CARCINOMA CELLSJournal of Liposome Research, 2002
- Tumor targetingin vivoby means of thermolabile fusogenic liposomesJournal of Drug Targeting, 1996
- Activity of Topotecan, a New Topoisomerase I Inhibitor, Against Human Tumor Colony-Forming Units In VitroJNCI Journal of the National Cancer Institute, 1992
- Kinetic Analysis of Combination Effect of Navelbine (KW-2307) with Cisplatin against Human Lung Adenocarcinoma PC-12 Cells in CultureJapanese Journal of Cancer Research, 1992
- Temperature-sensitive release of adriamycin, an amphiphilic antitumor agent, from dipalmitoylphosphatidylcholine-cholesterol liposomesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1989
- Vesicles of variable sizes produced by a rapid extrusion procedureBiochimica et Biophysica Acta (BBA) - Biomembranes, 1986
- Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potentialBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985